These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 10837594)
21. Barriers to Liposomal Gene Delivery: from Application Site to the Target. Saffari M; Moghimi HR; Dass CR Iran J Pharm Res; 2016; 15(Suppl):3-17. PubMed ID: 28228799 [TBL] [Abstract][Full Text] [Related]
22. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160 [TBL] [Abstract][Full Text] [Related]
23. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902 [TBL] [Abstract][Full Text] [Related]
24. Sortagging of liposomes with a murine CD11b-specific VHH increases in vitro and in vivo targeting specificity of myeloid cells. Wöll S; Bachran C; Schiller S; Schröder M; Conrad L; Scherließ R; Swee LK Eur J Pharm Biopharm; 2019 Jan; 134():190-198. PubMed ID: 30468837 [TBL] [Abstract][Full Text] [Related]
25. Use of liposomes as injectable-drug delivery systems. Ostro MJ; Cullis PR Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806 [TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature. Sakurai Y; Kajimoto K; Harashima H Biomater Sci; 2015 Sep; 3(9):1253-65. PubMed ID: 26261854 [TBL] [Abstract][Full Text] [Related]
27. Entrapment of small molecules and nucleic acid-based drugs in liposomes. Fenske DB; Cullis PR Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372 [TBL] [Abstract][Full Text] [Related]
29. Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells. Düzgüneş N; Pretzer E; Simões S; Slepushkin V; Konopka K; Flasher D; de Lima MC Mol Membr Biol; 1999; 16(1):111-8. PubMed ID: 10332745 [TBL] [Abstract][Full Text] [Related]
30. Intracellular delivery of nanocarriers and targeting to subcellular organelles. Jhaveri A; Torchilin V Expert Opin Drug Deliv; 2016; 13(1):49-70. PubMed ID: 26358656 [TBL] [Abstract][Full Text] [Related]
31. Chapter 14 - Synthesis, characterization, and optical response of gold nanoshells used to trigger release from liposomes. Wu G; Mikhailovsky A; Khant HA; Zasadzinski JA Methods Enzymol; 2009; 464():279-307. PubMed ID: 19903560 [TBL] [Abstract][Full Text] [Related]
32. Interactions of liposomes with mammalian cells. Pagano RE; Weinstein JN Annu Rev Biophys Bioeng; 1978; 7():435-68. PubMed ID: 352245 [TBL] [Abstract][Full Text] [Related]
33. Sortaggable liposomes: Evaluation of reaction conditions for single-domain antibody conjugation by Sortase-A and targeting of CD11b Wöll S; Bachran C; Schiller S; Schröder M; Conrad L; Swee LK; Scherließ R Eur J Pharm Biopharm; 2018 Dec; 133():138-150. PubMed ID: 30266669 [TBL] [Abstract][Full Text] [Related]
34. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Zhong Y; Meng F; Deng C; Zhong Z Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476 [TBL] [Abstract][Full Text] [Related]
35. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. Gregoriadis G; Florence AT Drugs; 1993 Jan; 45(1):15-28. PubMed ID: 7680982 [TBL] [Abstract][Full Text] [Related]
36. Liposome targeting to tumors using vitamin and growth factor receptors. Drummond DC; Hong K; Park JW; Benz CC; Kirpotin DB Vitam Horm; 2000; 60():285-332. PubMed ID: 11037627 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms and kinetics of liposome-cell interactions. Düzgüneş N; Nir S Adv Drug Deliv Rev; 1999 Nov; 40(1-2):3-18. PubMed ID: 10837777 [TBL] [Abstract][Full Text] [Related]
38. Ligand-targeted liposomal therapies of neuroblastoma. Pastorino F; Marimpietri D; Brignole C; Di Paolo D; Pagnan G; Daga A; Piccardi F; Cilli M; Allen TM; Ponzoni M Curr Med Chem; 2007; 14(29):3070-8. PubMed ID: 18220743 [TBL] [Abstract][Full Text] [Related]
39. On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems - A commentary. Johnsen KB; Gudbergsson JM; Duroux M; Moos T; Andresen TL; Simonsen JB J Control Release; 2018 Jan; 269():10-14. PubMed ID: 29126999 [TBL] [Abstract][Full Text] [Related]
40. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]